TSPO

Eero Polvinen1, Markus Matilainen1, Marjo Nylund1

  • 1From the Turku PET Centre (E.P., M.M., M.N., M.S., L.M.A.); Clinical Neurosciences (E.P., M.N., M.S., L.M.A.), University of Turku; Faculty of Science and Engineering (M.M.), Åbo Akademi University; and Neurocenter (M.S., L.M.A.), Turku University Hospital, Finland.

概括

通过TSPO-PET成像检测到的慢性活性病变的频率预测了多发性硬化症 (MS) 疾病的进展. 较高比例的边缘活性病变表明MS患者残疾累积的风险更大.